Abnormal Psychology and Disorders › lesson 36 of 100 · Intermediate
Describe Schizophrenia Pathophysiology
This lesson is part of the Abnormal Psychology and Disorders course, and after completing it, you will be able to describe the pathophysiology of schizophrenia. You will understand the underlying biological mechanisms that contribute to the development of this complex mental disorder.
The pathophysiology of schizophrenia involves a complex interplay of genetic, neurochemical, and neuroanatomical factors that disrupt normal brain function.
A 25-year-old man, diagnosed with schizophrenia, exhibits disorganized thinking, hallucinations, and delusions. This presentation is characteristic of the disorder, which is thought to result from dopamine dysregulation in the brain, particularly in the prefrontal cortex and striatum. The hypofunction of NMDA receptors and the hyperfunction of dopamine D2 receptors are also implicated in the development of schizophrenia.
The neurodevelopmental hypothesis proposes that schizophrenia results from abnormal brain development, including neuronal migration and synaptogenesis. This hypothesis is supported by findings of reduced cortical thickness and enlarged lateral ventricles in individuals with schizophrenia.
Additionally, inflammation and oxidative stress have been linked to the pathophysiology of schizophrenia, with elevated levels of pro-inflammatory cytokines and reduced antioxidant defenses observed in individuals with the disorder.
Приклади
- A patient with schizophrenia exhibits a significant reduction in cortical thickness, which is associated with cognitive impairment.This example illustrates the neuroanatomical abnormalities that contribute to the pathophysiology of schizophrenia.
- A study finds that individuals with schizophrenia have elevated levels of pro-inflammatory cytokines, which are associated with symptom severity.This example highlights the role of inflammation in the pathophysiology of schizophrenia.
- A patient with schizophrenia is treated with an antipsychotic medication that targets dopamine D2 receptors, resulting in improved symptoms.This example demonstrates the effectiveness of pharmacological interventions that target the neurochemical abnormalities underlying schizophrenia.
Повний курс перевіряє кожен урок 5 питаннями, підлаштовується під ваш рівень і пам'ятає ваше місце.